Akr1b15 Rat 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of AKR1B8 mRNA CTD PMID:21983209 Akr1b15 Rat 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of AKR1B8 mRNA CTD PMID:30723492 Akr1b15 Rat 1-phenyl-1,2-propanedione multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of 1-phenyl-1,2-propanedione CTD PMID:18845131 Akr1b15 Rat 16-Ketoestrone multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of 16-ketoestrone CTD PMID:18845131 Akr1b15 Rat 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of AKR1B8 mRNA CTD PMID:17557909 Akr1b15 Rat 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of AKR1B8 mRNA CTD PMID:17108234 Akr1b15 Rat 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AKR1B8 mRNA CTD PMID:32741896 Akr1b15 Rat 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AKR1B8 mRNA CTD PMID:32741896 Akr1b15 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKR1B8 mRNA CTD PMID:34747641 Akr1b15 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AKR1B8 mRNA CTD PMID:16960034|PMID:21215274 Akr1b15 Rat 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of AKR1B8 mRNA CTD PMID:21346803 Akr1b15 Rat 2,4-Nonadienal multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of 2,4-nonadienal CTD PMID:18845131 Akr1b15 Rat 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of AKR1B8 mRNA CTD PMID:17109745 Akr1b15 Rat 2-hexenal multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of 2-hexenal CTD PMID:18845131 Akr1b15 Rat 2-palmitoylglycerol increases expression ISO AKR1B15 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of AKR1B15 mRNA CTD PMID:37199045 Akr1b15 Rat 21-dehydrocortisol multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of 21-dehydrocortisol CTD PMID:18845131 Akr1b15 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of AKR1B8 mRNA CTD PMID:28300664 Akr1b15 Rat 3-deoxyglucosone multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of 3-deoxyglucosone CTD PMID:18845131 Akr1b15 Rat 3-pyridinemethanol multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the oxidation of Nicotinyl Alcohol CTD PMID:18845131 Akr1b15 Rat 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4,4'-diaminodiphenylmethane results in increased expression of AKR1B8 mRNA CTD PMID:30723492 Akr1b15 Rat 4-hydroxynon-2-enal multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of 4-hydroxy-2-nonenal CTD PMID:18845131 Akr1b15 Rat 4-nitrobenzaldehyde increases metabolic processing ISO AKR1B15 (Homo sapiens) 6480464 AKR1B15 protein results in increased metabolism of 4-nitrobenzaldehyde CTD PMID:21276782 Akr1b15 Rat 4-nitrobenzaldehyde multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of 4-nitrobenzaldehyde CTD PMID:18845131 Akr1b15 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of AKR1B8 mRNA CTD PMID:31881176 Akr1b15 Rat acrolein multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of Acrolein CTD PMID:18845131 Akr1b15 Rat aflatoxin B1 increases methylation ISO AKR1B15 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of AKR1B15 gene CTD PMID:27153756 Akr1b15 Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of AKR1B8 mRNA CTD PMID:23630614|PMID:25378103 Akr1b15 Rat aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of AKR1B8 mRNA CTD PMID:17109745 Akr1b15 Rat all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of AKR1B8 mRNA CTD PMID:20488242 Akr1b15 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AKR1B8 mRNA CTD PMID:16483693 Akr1b15 Rat amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of AKR1B8 mRNA CTD PMID:30779732 Akr1b15 Rat aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of AKR1B8 mRNA CTD PMID:17483316 Akr1b15 Rat aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of AKR1B8 mRNA CTD PMID:23912714 Akr1b15 Rat arsane affects methylation ISO AKR1B15 (Homo sapiens) 6480464 Arsenic affects the methylation of AKR1B15 gene CTD PMID:25304211 Akr1b15 Rat arsane increases expression EXP 6480464 Arsenic results in increased expression of AKR1B8 mRNA CTD PMID:18315880 Akr1b15 Rat arsenic atom affects methylation ISO AKR1B15 (Homo sapiens) 6480464 Arsenic affects the methylation of AKR1B15 gene CTD PMID:25304211 Akr1b15 Rat arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of AKR1B8 mRNA CTD PMID:18315880 Akr1b15 Rat arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of AKR1B8 protein CTD PMID:15175009 Akr1b15 Rat arsenite(3-) multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [arsenite results in increased expression of AKR1B8 protein]; Glutathione inhibits the more ... CTD PMID:15175009 Akr1b15 Rat benzaldehyde multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of benzaldehyde CTD PMID:18845131 Akr1b15 Rat benzbromarone decreases activity EXP 6480464 Benzbromarone results in decreased activity of AKR1B8 protein CTD PMID:18845131 Akr1b15 Rat benzo[a]pyrene increases expression ISO AKR1B15 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of AKR1B15 mRNA CTD PMID:22316170|PMID:32234424 Akr1b15 Rat benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of AKR1B8 mRNA CTD PMID:21839799 Akr1b15 Rat benzo[a]pyrene increases methylation ISO AKR1B15 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of AKR1B15 exon; Benzo(a)pyrene results in increased methylation of AKR1B15 more ... CTD PMID:27901495 Akr1b15 Rat benzyl alcohol multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the oxidation of Benzyl Alcohol CTD PMID:18845131 Akr1b15 Rat beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of AKR1B8 mRNA CTD PMID:17109745 Akr1b15 Rat beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR1B8 mRNA CTD PMID:18164116 Akr1b15 Rat bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of AKR1B8 mRNA CTD PMID:19560483 Akr1b15 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of AKR1B15 mRNA CTD PMID:25181051 Akr1b15 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AKR1B8 mRNA CTD PMID:30816183|PMID:32145629|PMID:32528016 Akr1b15 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AKR1B8 mRNA CTD PMID:30903817 Akr1b15 Rat bisphenol AF increases expression EXP 6480464 bisphenol AF results in increased expression of AKR1B8 mRNA CTD PMID:39938710 Akr1b15 Rat bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of AKR1B8 mRNA CTD PMID:20830808 Akr1b15 Rat butan-1-ol multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the oxidation of 1-Butanol CTD PMID:18845131 Akr1b15 Rat butanal multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of butyraldehyde CTD PMID:18845131 Akr1b15 Rat butane-2,3-dione multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of Diacetyl CTD PMID:18845131 Akr1b15 Rat Butylbenzyl phthalate increases expression EXP 6480464 butylbenzyl phthalate results in increased expression of AKR1B8 mRNA CTD PMID:19560483 Akr1b15 Rat cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of AKR1B8 mRNA CTD PMID:18500788 Akr1b15 Rat chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of AKR1B8 mRNA CTD PMID:23125180 Akr1b15 Rat cisplatin multiple interactions ISO AKR1B15 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of AKR1B15 mRNA CTD PMID:27392435 Akr1b15 Rat cisplatin increases expression ISO AKR1B15 (Homo sapiens) 6480464 Cisplatin results in increased expression of AKR1B15 mRNA CTD PMID:27392435 Akr1b15 Rat cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of AKR1B8 mRNA; cobaltous chloride results in increased expression more ... CTD PMID:24386269 Akr1b15 Rat copper atom decreases expression EXP 6480464 Copper results in decreased expression of AKR1B8 mRNA CTD PMID:30556269 Akr1b15 Rat copper(0) decreases expression EXP 6480464 Copper results in decreased expression of AKR1B8 mRNA CTD PMID:30556269 Akr1b15 Rat copper(II) sulfate increases expression ISO AKR1B15 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of AKR1B15 mRNA CTD PMID:19549813 Akr1b15 Rat coumarin increases expression EXP 6480464 coumarin results in increased expression of AKR1B8 mRNA CTD PMID:18480146 Akr1b15 Rat curcumin increases expression EXP 6480464 Curcumin results in increased expression of AKR1B8 mRNA CTD PMID:18299980 Akr1b15 Rat cytarabine decreases expression ISO AKR1B15 (Homo sapiens) 6480464 Cytarabine results in decreased expression of AKR1B15 mRNA CTD PMID:21198554 Akr1b15 Rat D-glyceraldehyde increases metabolic processing ISO AKR1B15 (Homo sapiens) 6480464 AKR1B15 protein results in increased metabolism of Glyceraldehyde CTD PMID:21276782 Akr1b15 Rat decan-1-ol multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the oxidation of n-decyl alcohol CTD PMID:18845131 Akr1b15 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of AKR1B8 mRNA CTD PMID:19560483 Akr1b15 Rat diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of AKR1B8 mRNA CTD PMID:36653537 Akr1b15 Rat dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of AKR1B8 mRNA CTD PMID:37567419 Akr1b15 Rat dipentyl phthalate increases expression EXP 6480464 di-n-pentyl phthalate results in increased expression of AKR1B8 mRNA CTD PMID:19560483 Akr1b15 Rat diuron increases expression EXP 6480464 Diuron results in increased expression of AKR1B8 mRNA CTD PMID:21551480|PMID:25152437 Akr1b15 Rat ferric oxide increases expression EXP 6480464 ferric oxide analog results in increased expression of AKR1B8 mRNA CTD PMID:38615722 Akr1b15 Rat Fidarestat decreases activity EXP 6480464 fidarestat results in decreased activity of AKR1B8 protein CTD PMID:18845131 Akr1b15 Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of AKR1B8 mRNA; Flutamide results in increased expression of AKR1B8 more ... CTD PMID:17311803|PMID:24136188 Akr1b15 Rat furan increases expression EXP 6480464 furan results in increased expression of AKR1B8 mRNA CTD PMID:26194646 Akr1b15 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of AKR1B8 mRNA CTD PMID:33387578 Akr1b15 Rat glutathione multiple interactions EXP 6480464 Glutathione inhibits the reaction [arsenite results in increased expression of AKR1B8 protein] CTD PMID:15175009 Akr1b15 Rat glyceraldehyde increases metabolic processing ISO AKR1B15 (Homo sapiens) 6480464 AKR1B15 protein results in increased metabolism of Glyceraldehyde CTD PMID:21276782 Akr1b15 Rat glycolaldehyde multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of glycolaldehyde CTD PMID:18845131 Akr1b15 Rat glyoxal multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of Glyoxal CTD PMID:18845131 Akr1b15 Rat hexan-1-ol multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the oxidation of 1-hexanol CTD PMID:18845131 Akr1b15 Rat hexane-2,3-dione multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of 2,3-hexanedione CTD PMID:18845131 Akr1b15 Rat hexestrol decreases activity EXP 6480464 Hexestrol results in decreased activity of AKR1B8 protein CTD PMID:18845131 Akr1b15 Rat indan-1-ol multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the oxidation of 1-indanol CTD PMID:18845131 Akr1b15 Rat indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AKR1B8 mRNA CTD PMID:22129741 Akr1b15 Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of AKR1B8 mRNA CTD PMID:21396975 Akr1b15 Rat indometacin increases expression EXP 6480464 Indomethacin results in increased expression of AKR1B8 mRNA CTD PMID:36868495 Akr1b15 Rat isatin multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of Isatin CTD PMID:18845131 Akr1b15 Rat ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of AKR1B8 mRNA CTD PMID:36653537 Akr1b15 Rat lipopolysaccharide multiple interactions ISO AKR1B15 (Homo sapiens) 6480464 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of AKR1B15 mRNA CTD PMID:35811015 Akr1b15 Rat methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of AKR1B8 mRNA CTD PMID:30467583 Akr1b15 Rat methylglyoxal multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of Pyruvaldehyde CTD PMID:18845131 Akr1b15 Rat minalrestat decreases activity EXP 6480464 minalrestat results in decreased activity of AKR1B8 protein CTD PMID:18845131 Akr1b15 Rat myricetin decreases activity EXP 6480464 myricetin results in decreased activity of AKR1B8 protein CTD PMID:18845131 Akr1b15 Rat N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [arsenite results in increased expression of AKR1B8 protein] CTD PMID:15175009 Akr1b15 Rat N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of AKR1B8 protein CTD PMID:11565795 Akr1b15 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR1B8 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] more ... CTD PMID:18164116|PMID:22129741|PMID:28943392 Akr1b15 Rat N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of AKR1B8 mRNA; Diethylnitrosamine results in increased expression of AKR1B8 more ... CTD PMID:11565795|PMID:19638242 Akr1b15 Rat N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of AKR1B8 protein CTD PMID:11565795 Akr1b15 Rat N-Nitrosopyrrolidine increases expression ISO AKR1B15 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in increased expression of AKR1B15 mRNA CTD PMID:32234424 Akr1b15 Rat NADP zwitterion multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the oxidation of 1-Butanol; [AKR1B8 protein co-treated with NADP] more ... CTD PMID:18845131 Akr1b15 Rat NADP(+) multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the oxidation of 1-Butanol; [AKR1B8 protein co-treated with NADP] more ... CTD PMID:18845131 Akr1b15 Rat naphthalene increases expression EXP 6480464 naphthalene analog results in increased expression of AKR1B8 mRNA CTD PMID:24976557 Akr1b15 Rat nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of AKR1B8 mRNA CTD PMID:22110744 Akr1b15 Rat nitrofen increases expression EXP 6480464 nitrofen results in increased expression of AKR1B8 mRNA CTD PMID:33484710 Akr1b15 Rat non-2-enal multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of 2-nonenal CTD PMID:18845131 Akr1b15 Rat nonan-1-ol multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the oxidation of 1-nonanol CTD PMID:18845131 Akr1b15 Rat Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of AKR1B8 protein CTD PMID:19260726 Akr1b15 Rat O-methyleugenol increases expression ISO AKR1B15 (Homo sapiens) 6480464 methyleugenol results in increased expression of AKR1B15 mRNA CTD PMID:32234424 Akr1b15 Rat okadaic acid increases expression ISO AKR1B15 (Homo sapiens) 6480464 Okadaic Acid results in increased expression of AKR1B15 mRNA CTD PMID:38832940 Akr1b15 Rat organophosphorus compound multiple interactions EXP 6480464 [Dust results in increased abundance of Organophosphorus Compounds] which results in increased expression of AKR1B8 more ... CTD PMID:39658253 Akr1b15 Rat oxaliplatin multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in increased expression of AKR1B8 mRNA CTD PMID:25729387 Akr1b15 Rat oxaliplatin increases expression EXP 6480464 Oxaliplatin results in increased expression of AKR1B8 mRNA CTD PMID:25729387 Akr1b15 Rat ozone increases expression EXP 6480464 Ozone results in increased expression of AKR1B8 mRNA CTD PMID:16716893 Akr1b15 Rat p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of AKR1B8 mRNA CTD PMID:27638505 Akr1b15 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of AKR1B8 mRNA CTD PMID:33387578 Akr1b15 Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of AKR1B8 mRNA CTD PMID:32680482 Akr1b15 Rat pentane-2,3-dione multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of 2,3-pentanedione CTD PMID:18845131 Akr1b15 Rat phenacetin increases expression EXP 6480464 Phenacetin results in increased expression of AKR1B8 mRNA CTD PMID:17698508 Akr1b15 Rat Phenylglyoxal multiple interactions EXP 6480464 [AKR1B8 protein co-treated with NADP] affects the reduction of Phenylglyoxal CTD PMID:18845131 Akr1b15 Rat phenylhydrazine increases expression EXP 6480464 phenylhydrazine results in increased expression of AKR1B8 mRNA CTD PMID:17698508 Akr1b15 Rat quercetin increases expression EXP 6480464 Quercetin results in increased expression of AKR1B8 mRNA CTD PMID:19191009 Akr1b15 Rat quercetin decreases activity EXP 6480464 Quercetin results in decreased activity of AKR1B8 protein CTD PMID:18845131 Akr1b15 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO AKR1B15 (Homo sapiens) 6480464 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of AKR1B15 mRNA CTD PMID:35811015 Akr1b15 Rat sodium arsenite increases expression ISO AKR1B15 (Homo sapiens) 6480464 sodium arsenite results in increased expression of AKR1B15 mRNA CTD PMID:28595984|PMID:34032870 Akr1b15 Rat sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of AKR1B8 mRNA CTD PMID:22110744 Akr1b15 Rat Soman increases expression EXP 6480464 Soman results in increased expression of AKR1B8 mRNA CTD PMID:19281266 Akr1b15 Rat sorbinil decreases activity EXP 6480464 sorbinil results in decreased activity of AKR1B8 protein CTD PMID:18845131 Akr1b15 Rat tauroursodeoxycholic acid increases expression EXP 6480464 ursodoxicoltaurine results in increased expression of AKR1B8 mRNA CTD PMID:15885361 Akr1b15 Rat temozolomide decreases expression ISO AKR1B15 (Homo sapiens) 6480464 Temozolomide results in decreased expression of AKR1B15 mRNA CTD PMID:31758290 Akr1b15 Rat testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AKR1B8 mRNA CTD PMID:32741896 Akr1b15 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of AKR1B8 mRNA CTD PMID:23411599 Akr1b15 Rat thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AKR1B8 mRNA CTD PMID:28943392 Akr1b15 Rat tolrestat decreases activity EXP 6480464 tolrestat results in decreased activity of AKR1B8 protein CTD PMID:18845131 Akr1b15 Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of AKR1B8 mRNA CTD PMID:25729387 Akr1b15 Rat topotecan multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in increased expression of AKR1B8 mRNA CTD PMID:25729387 Akr1b15 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of AKR1B8 mRNA CTD PMID:33387578 Akr1b15 Rat trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of AKR1B8 gene CTD PMID:27618143 Akr1b15 Rat triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of AKR1B8 mRNA CTD PMID:30589522 Akr1b15 Rat Triptolide increases expression EXP 6480464 triptolide results in increased expression of AKR1B8 protein CTD PMID:32519852 Akr1b15 Rat troglitazone increases expression ISO AKR1B15 (Homo sapiens) 6480464 Troglitazone results in increased expression of AKR1B15 mRNA CTD PMID:25572481 Akr1b15 Rat urethane decreases expression ISO AKR1B15 (Homo sapiens) 6480464 Urethane results in decreased expression of AKR1B15 mRNA CTD PMID:28818685 Akr1b15 Rat ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of AKR1B8 mRNA CTD PMID:15885361 Akr1b15 Rat zearalenone decreases activity EXP 6480464 Zearalenone results in decreased activity of AKR1B8 protein CTD PMID:18845131 Akr1b15 Rat zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of AKR1B8 mRNA CTD PMID:16140947 Akr1b15 Rat zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of AKR1B8 mRNA] CTD PMID:16140947 Akr1b15 Rat zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of AKR1B8 mRNA] CTD PMID:16140947 Akr1b15 Rat zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of AKR1B8 mRNA CTD PMID:16140947